News | May 11, 2022
Bayer posts higher sales, profit in first quarter
Company's net income rose by 57.5 percent to 3.291 billion euros in Q1
Company's net income rose by 57.5 percent to 3.291 billion euros in Q1
Pfizer to commercialize NURTEC ODT (rimegepant), an innovative compound for the prevention and acute treatment of migraine, a condition with high unmet need
Under the 5-year exclusive agreement, Artemis DNA will provide Datar's pioneering cancer detection Liquid Biopsies in the USA and Vietnam markets
There is a need for the Ministry of Health to put it on the priority list and address the issues, which are numerous
RNAstorm and DNAstorm RNA/DNA extraction kits will be sold exclusively through the Biotium website and authorized distributors
In the UK, Bartec has been synonymous with Mediso products for 18 years, proof of a successful partnership
Formula attenuates 99% of 365 coronaviruses in computer models
CIVCO RT will also display its recent innovations focusing on improving patient comfort and outcomes
Avacc 3 has significant advantages over existing whooping cough vaccines
The companies expect to complete the submission of the NDA for treatment of MDD in the second half of 2022; associated filing for postpartum depression is anticipated in the first half of 2023
Subscribe To Our Newsletter & Stay Updated
